WeiJiangMDPhD

Pathology • Philadelphia, PA

Gastrointestinal & Hepatobiliary Pathology, Anatomic Pathology, Clinical Pathology, Surgical Pathology

Associate Professor

Join to view full profile

Dr. Jiang is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Jiang's full profile

Already have an account?

Office
132 S 10th St
Ste 285K
Philadelphia, PA 19107
Phone+1 215-503-5642

Fax+1 215-503-4817

Education & Training

Cleveland Clinic FoundationResidency, Pathology-Anatomic and Clinical, 2008 - 2011
Johns Hopkins University School of MedicineInternship, Transitional Year, 2007 - 2008
Massachusetts General HospitalPost-Doctoral Fellowship, 2002 - 2007
Syracuse UniversityPhD, Biology, 1995 - 2001
Beijing Medical UniversityClass of 1995

Certifications & Licensure

NJ State Medical License 2019 - 2025
PA State Medical License 2011 - 2024
OH State Medical License 2008 - 2012
American Board of Pathology Pathology - Anatomic/Pathology - Clinical

Publications & Presentations

PubMed

51 citations
Epigenetics: Roles and therapeutic implications of non-coding RNA modifications in human cancers
Dawei Rong, Guangshun Sun, Fan Wu, Ye Cheng, Guoqiang Sun
Molecular Therapy. Nucleic Acids. 2021-05-01
79 citations
RRx-001 ameliorates inflammatory diseases by acting as a potent covalent NLRP3 inhibitor.
Yun Chen, Hongbin He, Bolong Lin, Xianming Deng, Wei Jiang
Cellular & Molecular Immunology. 2021-05-10
4 citations
Extracellular Acidity Reprograms Macrophage Metabolism and Innate Responsiveness.
Wei Jiang, James Le, Ping Yuan Wang, Xiaofang Cheng, Margery G. Smelkinson
Journal of Immunology. 2021-06-09

Lectures

Apatinib for locoregionally recurrent or metastatic nasopharyngeal carcinoma after failure of first-line chemotherapy: A multicenter, phase II trial.
2019 ASCO Annual Meeting - 6/1/2019

Press Mentions

Differential Expression of αVβ3 and αVβ6 Integrins in Prostate Cancer ProgressionJanuary 22nd, 2021
The Genetic Origins of Sex Differences in DiseaseSeptember 17th, 2019
SLE Breakthrough Finds a Link Between Microbial Translocation and AutoantibodiesAugust 7th, 2019